Physician profile
Christopher Spolarich
NPI 1568969749
$31,036.82
in general payments reported to CMS, 2019-2025
9 companies · $2,835 in 2025
The $2,835 reported for 2025 was more than what 75% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,417 · 2021: $8,468 · 2022: $4,842 · 2023: $10K · 2024: $2,010 · 2025: $2,835.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $11K · Travel and Lodging: $2,694 · Food and Beverage: $2,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,500.00 |
| Travel and Lodging | $2,693.73 |
| Food and Beverage | $2,115.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rock Medical Orthopedics, INC. | $15,727.45 | 2020-2022 | |
| Arthrex, INC. | $12,356.87 | 2023-2025 | |
| Stryker Corporation | $950.39 | 2023-2025 | Mako, Aequalis Perform Reversed, Profyle |
| Nexus Medical Technologies LLC | $840.23 | 2025 | |
| Zimmer Biomet Holdings, INC. | $791.46 | 2023-2025 | Oss Orthopedic Salvage System, Juggerstitch |
| Gotham Surgical Solutions & Devices, INC. | $181.14 | 2025 | |
| Smith+Nephew, INC. | $137.72 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Redapt |
| Vericel Corporation | $37.75 | 2023 | Maci |
| Acumed LLC | $13.81 | 2025 | Innate Implant, Acumed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Spolarich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.